No one outside the company knows for sure. The h

No one outside the company knows for sure. The have mentioned licensing the prostate parts, apparently NP was very impressive with RP during these negotiations. And the moves up the filing, so I’m assuming that is getting closer. Many people are frustrated with the word soon or close though. They could do more Paulson, from the share price drop, that is the market’s current expectations. It it were me, I would limb along raising 3.5M per month until the science becomes so overwhelming (aka cancer data or mono pivotal or BLA submission), it breaks free, or until they hit revenue. Many people have probably been in a situation, senior year of college with bills, credit cards, you know income is coming next year, you don’t pay off the credit cards before income, you pay the monthly payment until you hit revenue. Some of those numbers being spit out on the other site is the cost to be debt free, which no company ever is, you have a revolving balance which you pay down monthly and reuse the credit.

Were you at the presentation today?